Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer

BACKGROUND: Many prostate cancers demonstrate an increased expression of growth factor receptors such as vascular endothelial growth factor receptor (VEGFR) and platelet derived growth factor receptor (PDGFR) which have been correlated with increased resistance to radiotherapy and poor prognosis in...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Brooks, Colin, Sheu, Tommy, Bridges, Kathleen, Mason, Kathy, Kuban, Deborah, Mathew, Paul, Meyn, Raymond
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2012
נושאים:
Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3494537/
https://ncbi.nlm.nih.gov/pubmed/22967802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-7-154
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים